![Sherwin Sattarzadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sherwin Sattarzadeh
Keine laufenden Positionen mehr
Vermögen: 5 Mio $ am 30.06.2026
Profil
Mr. Sherwin Sattarzadeh was previously employed as a Chief Executive & Operating Officer by Damora Therapeutics, Inc., a Chief Business Officer by Blueprint Medicines Corp., and a Director-Regulatory Affairs by Genzyme Corp.
He received his undergraduate degree from the University of British Columbia and an MBA from Boston University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.01.2026 | 190 376 ( 0,31 % ) | 5 Mio $ | 30.06.2026 |
Ehemalige bekannte Positionen von Sherwin Sattarzadeh
| Unternehmen | Position | Ende |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Vorstandsvorsitzender | 30.03.2026 |
| BLUEPRINT MEDICINES CORPORATION | Personalreferent | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 01.07.2015 |
Ausbildung von Sherwin Sattarzadeh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
